[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Yellow card myocarditis warning", "description": "Yellow card scheme, Don\u2019t wait for someone else to report it\n\nhttps://www.gov.uk/drug-safety-update/yellow-card-please-help-to-reverse-the-decline-in-reporting-of-suspected-adverse-drug-reactions\n\nIt is estimated that only 10% of serious reactions and between 2 and 4% of non-serious reactions are reported. \n\nYellow card government site, just a click away\n\nhttps://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting\n\nAs of 23 November 2022, (UK)\n\nPfizer/BioNTech, monovalent and bivalent \n\n177,925 Yellow Cards have been reported\n\nAstraZeneca\n\n246,866 have been reported\n\nModerna, monovalent and bivalent\n\n47,045 have been reported\n\nNovavax\n\n52 reports\n\nBrand of vaccine was not specified\n\n2,130 reports\n\nTotal reports\n\n474,018\n\nOverall reporting rate\n\nAround 2 to 5 Yellow Cards per 1,000 doses administered\n\nIn the 28 days\n\nPfizer/BioNTech, + 2,499 reports\n\nAstraZeneca, + 228\n\nModerna, + 1,099\n\nNovavax, + 15\n\nBrand not specified, + 154\n\nFor all COVID-19 vaccines\n\ninjection-site reactions (sore arm for example)\n\ngeneralised symptoms such as \u2018flu-like\u2019 illness\n\nheadache, chills, fatigue (tiredness), nausea (feeling sick), fever, dizziness, weakness, aching muscles, rapid heartbeat\n\nthey may be reported more frequently in younger adults\n\nOverall, our advice remains that the benefits of the vaccines outweigh the risks in the majority of people. \n\nThe benefits of the vaccines in preventing COVID-19 and serious complications associated with COVID-19 far outweigh any currently known side effects in the majority of patients.\n\nhttps://wchh.onlinelibrary.wiley.com/doi/pdf/10.1002/psb.1789\n\nGoogle YT guidelines\nhttps://support.google.com/youtube/answer/9891785\n\nClaims that an approved COVID-19 vaccine will cause death, infertility, miscarriage, autism, or contraction of other infectious diseases\n\nhttps://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/information-for-healthcare-professionals-on-covid-19-vaccine-moderna\n\n4.4 Special warnings and precautions for use\n\nHypersensitivity and anaphylaxis\nAnaphylaxis has been reported in individuals who have received Spikevax. \n\nClose observation for at least 15 minutes is recommended following vaccination. \n\nMyocarditis and pericarditis\n\nThere is an increased risk for myocarditis and pericarditis following vaccination with Spikevax.\n\nFew days, primarily occurred within 14 days,\n\nmore often after the second dose,\n\nmore often in younger males\n\nrisk profile appears to be similar for the second and the third dose\n\nAvailable data suggest that the course of myocarditis and pericarditis following vaccination is not different from myocarditis or pericarditis in general.\n\nHealthcare professionals should be alert to the signs and symptoms of myocarditis and pericarditis. \n\nVaccinated individuals should be instructed to seek immediate medical attention if they develop symptoms indicative of myocarditis or pericarditis,\n\nsuch as (acute or persisting) chest pain, shortness of breath or palpitations following vaccination.\n\nHealthcare professionals should consult guidance and/or specialists to diagnose and treat this condition.\n\nWho can get a COVID-19 vaccine\n\nhttps://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/\n\nEveryone aged 5 (on or before 31 August 2022) and over can get a 1st and 2nd dose of the COVID-19 vaccine.\n\nPeople aged 16 and over, and some children aged 12 to 15, can also get a booster dose.\nHypertension after COVID-19 vaccination\nhttps://pubmed.ncbi.nlm.nih.gov/34985455/\n\nItalian research", "link": "https://www.youtube.com/watch?v=u0n-hUJM5n4", "date_published": "2022-12-20 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]